Reported Sunday, Takeda To Invest Up To $30M In Indonesia Plasma Ecosystem As Part Of Landmark Healthcare Collaboration With Indonesian Government, Including National Plasma Donation Network Pilot

Reported Earlier, JBS Forms JV With Indonesia Sovereign Fund Unit Danantara Investment Management To Expand Asian Protein Production; DIM To Commit $2.5B In Equity With Another $2.5B Of Debt Financing Planned

JBS USA Holding Lux S.à.r.l. ("JBS Holding") and PT Danantara Investment Management, the investment arm of Indonesia’s sovereign wealth fund ("DIM" and, together with JBS Holding, the "Parties"),

Takeda’s ORZEYFUL Wins Japan Approval For Narcolepsy Type 1 After Phase 3 Studies Show Significant Improvements Across Evaluated Symptoms

Royalty Pharma Locks in $100M Zealand Pharma Funding Pact for Blood Disorder Drug

Royalty Pharma will pay Zealand Pharma $100 million for economic rights tied to rusfertide, with FDA action expected in Q3 of 2026.

Vinod Khosla Says AI Is Creating a ‘Hyperabundance’ of New Drugs, but Testing Is Still ‘18th-Century’

Vinod Khosla says AI is revolutionizing drug discovery, but drug testing needs to catch up with more human-relevant methods.

Department Of Veterans Affairs Awards Takeda $5.6B Contract for Drugs And Biologicals Through 2031

https://sam.gov/opp/b8e3db55feb04369933f735cc6cda9aa/view